Skip to main content
Top
Published in: Reactions Weekly 1/2024

01-05-2024 | Colchicine | Clinical study

Prognostic factors for colchicine prophylaxis-related AEs

Published in: Reactions Weekly | Issue 1/2024

Login to get access

Excerpt

Patients receiving prophylactic colchicine when initiating allopurinol for gout are more likely to experience adverse events (AEs) if they have more comorbidities or are receiving potentially interacting medication, according to findings of a study published in Rheumatology.
Metadata
Title
Prognostic factors for colchicine prophylaxis-related AEs
Publication date
01-05-2024
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2024
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-57906-0

Other articles of this Issue 1/2024

Reactions Weekly 1/2024 Go to the issue

Case report

Apalutamide

Case report

Dulaglutide

Case report

Antineoplastics